Response to Comment on "Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice".
Eduardo A AlbornozRichard GordonVinod KumarAvril A B RobertsonKate SchroderTrent M WoodruffPublished in: Science translational medicine (2023)
We have replicated our original finding of elevated cleaved caspase-1 in mouse brains and neuroprotection by an NLRP3 inflammasome inhibitor in two mouse models of Parkinson's disease.